A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase

X-linked agammaglobulinemia (XLA) is a primary B cell immunodeficiency disorder, caused by a defect in the Bruton tyrosine kinase (BTK) gene. Here, we describe a novel four base pair mutation (838delGAGT) in intron 9 of the BTK gene leading to the skipping of exon 9 in a 2.5-year-old boy with...

Full description

Saved in:
Bibliographic Details
Main Authors: Lütfiye Mesci, Hilal Ozdag, Tuba Turul, Fügen Ersoy, Ilhan Tezcan, Ozden Sanal
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2006-10-01
Series:The Turkish Journal of Pediatrics
Online Access:https://turkjpediatr.org/article/view/2661
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025269856829440
author Lütfiye Mesci
Hilal Ozdag
Tuba Turul
Fügen Ersoy
Ilhan Tezcan
Ozden Sanal
author_facet Lütfiye Mesci
Hilal Ozdag
Tuba Turul
Fügen Ersoy
Ilhan Tezcan
Ozden Sanal
author_sort Lütfiye Mesci
collection DOAJ
description X-linked agammaglobulinemia (XLA) is a primary B cell immunodeficiency disorder, caused by a defect in the Bruton tyrosine kinase (BTK) gene. Here, we describe a novel four base pair mutation (838delGAGT) in intron 9 of the BTK gene leading to the skipping of exon 9 in a 2.5-year-old boy with this disorder.
format Article
id doaj-art-22b65d3faa0e426cb463b9a2cf1bbaca
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2006-10-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-22b65d3faa0e426cb463b9a2cf1bbaca2025-08-20T03:00:54ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212006-10-01484A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinaseLütfiye Mesci0Hilal OzdagTuba TurulFügen ErsoyIlhan TezcanOzden SanalImmunology Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. X-linked agammaglobulinemia (XLA) is a primary B cell immunodeficiency disorder, caused by a defect in the Bruton tyrosine kinase (BTK) gene. Here, we describe a novel four base pair mutation (838delGAGT) in intron 9 of the BTK gene leading to the skipping of exon 9 in a 2.5-year-old boy with this disorder. https://turkjpediatr.org/article/view/2661
spellingShingle Lütfiye Mesci
Hilal Ozdag
Tuba Turul
Fügen Ersoy
Ilhan Tezcan
Ozden Sanal
A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
The Turkish Journal of Pediatrics
title A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
title_full A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
title_fullStr A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
title_full_unstemmed A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
title_short A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase
title_sort novel mutation leading to a deletion in the sh3 domain of bruton s tyrosine kinase
url https://turkjpediatr.org/article/view/2661
work_keys_str_mv AT lutfiyemesci anovelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT hilalozdag anovelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT tubaturul anovelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT fugenersoy anovelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT ilhantezcan anovelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT ozdensanal anovelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT lutfiyemesci novelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT hilalozdag novelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT tubaturul novelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT fugenersoy novelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT ilhantezcan novelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase
AT ozdensanal novelmutationleadingtoadeletioninthesh3domainofbrutonstyrosinekinase